GH Secretagogue GHRP-2 Increases Body Fat Even in Mice Without NPY — Through Alternative Brain Pathways | Research

The takeaway

GHRP-2 increased fat mass in NPY knockout mice, proving that GH secretagogue-induced adiposity uses hypothalamic agouti-related protein (AgRP) pathways, not just the expected NPY pathway.

Backup pathway found
Even without NPY, GHRP-2 increased fat through AgRP — the appetite system is redundant, requiring multi-target approaches for obesity treatment

What the researchers found

GHRP-2 increased fat mass in NPY knockout mice, demonstrating that GH secretagogue-induced adiposity is mediated by hypothalamic AgRP rather than NPY, identifying a critical alternative pathway for ghrelin's metabolic effects.

Why it matters

Identifying AgRP as the mediator of ghrelin-induced fat gain provides a more specific therapeutic target. Blocking AgRP could potentially prevent the unwanted weight gain from GH secretagogues.

How the study worked

Animal study comparing GHRP-2 effects on body composition in NPY knockout versus wild-type mice. Fat mass, food intake, and hypothalamic neuropeptide expression measured.

What this study cannot tell us

NPY knockout mice may have compensatory mechanisms. The role of AgRP was inferred rather than directly proven. Other pathways may also contribute.

How to read the evidence

Preliminary animal evidence using a definitive genetic approach (NPY knockout) to demonstrate pathway redundancy.

When this study was published

Published in 2002. The AgRP pathway has been confirmed as a key mediator of ghrelin's metabolic effects, guiding anti-obesity drug development.

The bigger picture

The appetite/fat-storage system has backup pathways. Blocking one (NPY) doesn't prevent fat gain because another (AgRP) takes over. Effective anti-obesity therapy may need to target multiple pathways.

Questions still open

Could AgRP antagonists prevent GH secretagogue-induced weight gain?
Does dual NPY/AgRP targeting produce more effective appetite suppression?
Are other mediators involved beyond NPY and AgRP?

Common questions

Why is it so hard to prevent weight gain from GH peptides?

Because the appetite/fat system has backup pathways. Even without NPY (a major appetite signal), the AgRP pathway fills in. Preventing weight gain may require blocking multiple pathways simultaneously.

What is AgRP?

Agouti-related protein is a brain signal that promotes appetite and fat storage. It works alongside NPY but can function independently, as this study shows. It's now a key target for obesity drug development.

Read the original research

GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.

Endocrinology, 143(2), 558-68

View on PubMed ↗

Citation

Tschöp, Matthias; Statnick, Michael A; Suter, Todd M; Heiman, Mark L. (2002). GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.. Endocrinology, 143(2), 558-68.